Luc Friboulet, Ph.D Malaria .D., Jean-Pierre Pignon, M.D., Ph.D., Frances A. Shepherd, M.D., Ming-Sound Tsao, M.D., Stephen Graziano, M.D., Robert Kratzke, M.D., Jean-Yves Douillard, M.D., Ph.D., Lesley Seymour, M.D., Ph.D., Robert Pirker, M.D., Martin Filipits, Ph.D.D., Ph.D., Eric Solary, M.D., Ph.D., Florence Ponsonnailles, B.S.S., Annabelle Stoclin, M.D., Nicolas Dorvault, B.S.S., Julien Adam, M.D., Elsa Vanhecke, Ph.D., Patrick Saulnier, Ph.D.D., Thierry Le Chevalier, M.D., Ariane Dunant, M.S., Vanessa Rousseau, M.S.D., Elisabeth Brambilla, M.D., Ph.D., and Jean-Charles Soria, M.D., Ph.D.1,2 The identification of predictive biomarkers of the efficacy of adjuvant chemotherapy could lead to a better therapeutic index.3 DNA repair capacity is usually a significant determinant of cisplatin resistance; in particular, the excision repair cross-complementation group 1 protein has an essential part in nucleotide excision restoration.

68th AAD Annual Conference reveals science behind skincare Study presented by P&G Beauty & Grooming scientists in the 68th Annual Conference of the American Academy of Dermatology examines skincare science from multiple perspectives, offering insights into how ingredient formulations, treatment regimens and gene expressions effect skin condition. Eleven studies are on display, discussing an array of topics, including lipid metabolism pathways in the stratum corneum, epidermis elasticity and male shaving regimens. This year, P&G Beauty & Grooming is presenting a diverse analysis portfolio covering topics such as for example male and female condition of the skin, whole body anti-aging skin and remedies care genomics, said Emma Kohring, Global Director, P&G Beauty & Grooming Science.